CDAN1

Across TCGA pan-cancer cohorts, CDAN1 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated CDAN1 data layer compared with 27 for mass-spec protein and 8 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher CDAN1 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated CDAN1 expression acts as an unfavorable survival marker, although some lineages such as HNSC and LUAD show a favorable association.

HNSC and LUAD are the cancer types where CDAN1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Median	All	0.893	0.775	.027	6	view →
LUAD	DFS	Tertile	All	0.911	0.640	.048	3	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

CDAN1–HNSC (OS)

Open the HNSC breakdown →